UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

The Use of Model-Based Tumor-Size Metrics to Predict Survival

Clinical pharmacology and therapeutics, 2014-08, Vol.96 (2), p.133-135

2014

Volltextzugriff (PDF)

Role of modelling and simulation in Phase I drug development

European journal of pharmaceutical sciences, 2001-05, Vol.13 (2), p.115-122

2001

Volltextzugriff (PDF)

Development and implementation of the population Fisher information matrix for the evaluation of population pharmacokinetic designs

Computer methods and programs in biomedicine, 2001-05, Vol.65 (2), p.141-151

2001

Volltextzugriff (PDF)

The ISoP Standards and Best Practices Committee

Clinical pharmacology and therapeutics, 2014-06, Vol.95 (6), p.581-582

2014

Volltextzugriff (PDF)

Pharmacokinetic Similarity of Biologics: Analysis Using Nonlinear Mixed-Effects Modeling

Clinical pharmacology and therapeutics, 2012-02, Vol.91 (2), p.234-242

2012

Volltextzugriff (PDF)

Overview of model‐building strategies in population PK/PD analyses: 2002–2004 literature survey

British journal of clinical pharmacology, 2007-11, Vol.64 (5), p.603-612

2007

Volltextzugriff (PDF)

Hand contamination before and after different hand hygiene techniques: a randomized clinical trial

The Journal of hospital infection, 2002-04, Vol.50 (4), p.276-280

2002

Volltextzugriff (PDF)

Optimal design of a population pharmacodynamic experiment for ivabradine

Pharmaceutical research, 2001, Vol.18 (1), p.83-89

2001

Volltextzugriff (PDF)

Pharmacokinetic and Pharmacodynamic Variability of Fluindione in Octogenarians

Clinical pharmacology and therapeutics, 2012-05, Vol.91 (5), p.777-786

2012

Volltextzugriff (PDF)

Comparison of lithium concentrations in red blood cells and plasma in samples collected for TDM, acute toxicity, or acute-on-chronic toxicity

European journal of clinical pharmacology, 2003-11, Vol.59 (8-9), p.583-587

2003

Volltextzugriff (PDF)

Maintenance therapy with cotrimoxazole for toxoplasmic encephalitis in the era of highly active antiretroviral therapy

AIDS (London), 2004-06, Vol.18 (9), p.1342-1344

2004

Volltextzugriff (PDF)

Population pharmacokinetic analysis and optimization of the experimental design for mizolastine solution in children

Journal of pharmacokinetics and pharmacodynamics, 2001-06, Vol.28 (3), p.299-319

2001

Volltextzugriff (PDF)

Modelling and simulation in the development and use of anti-cancer agents : An underused tool?

Journal of pharmacokinetics and pharmacodynamics, 2004-12, Vol.31 (6), p.419-440

2004

Volltextzugriff (PDF)

Modeling the Kinetics of Release of Octreotide from Long‐Acting Formulations Injected Intramuscularly in Rabbits

Journal of pharmaceutical sciences, 2000-09, Vol.89 (9), p.1123-1133

2000

Volltextzugriff (PDF)

Fisher information matrix for non-linear mixed-effects models: evaluation and application for optimal design of enoxaparin population pharmacokinetics

Statistics in medicine, 2002-09, Vol.21 (18), p.2623-2639

2002

Volltextzugriff (PDF)

Robust optimal design for the estimation of hyperparameters in population pharmacokinetics

Journal of pharmacokinetics and biopharmaceutics, 1998-12, Vol.26 (6), p.689-716

1998

Volltextzugriff (PDF)

Nonparametric analysis of the absorption profile of octreotide in rabbits from long-acting release formulation OncoLAR

Journal of controlled release, 1999-05, Vol.59 (2), p.197-205

1999

Volltextzugriff (PDF)

Cerebral uptake of mefloquine enantiomers with and without the P‐gp inhibitor elacridar (GF1210918) in mice

British journal of pharmacology, 2004-04, Vol.141 (7), p.1214-1222

2004

Volltextzugriff (PDF)

Evolution of Human Immunodeficiency Virus Type 1 (HIV-1) Resistance Mutations in Nonnucleoside Reverse Transcriptase Inhibitors (NNRTIs) in HIV-1-Infected Patients Switched to Antiretroviral Therapy without NNRTIs

Antimicrobial Agents and Chemotherapy, 2004-01, Vol.48 (1), p.172-175

2004

Volltextzugriff (PDF)

Absence of association between MDR1 genetic polymorphisms, indinavir pharmacokinetics and response to highly active antiretroviral therapy

AIDS (London), 2005-12, Vol.19 (18), p.2127-2131

2005

Volltextzugriff (PDF)

Non-linear mixed effects modeling : From methodology and software development to driving implementation in drug development science

Journal of pharmacokinetics and pharmacodynamics, 2005-04, Vol.32 (2), p.161-183

2005

Volltextzugriff (PDF)

Prediction of fluindione maintenance dosage hampered by large intraindividual variability

Therapeutic drug monitoring, 2000-12, Vol.22 (6), p.668-675

2000

Volltextzugriff (PDF)

Optimization of individual and population designs using Splus

Journal of pharmacokinetics and pharmacodynamics, 2003-12, Vol.30 (6), p.417-443

2003

Volltextzugriff (PDF)

Optimal sampling times for bayesian estimation of the pharmacokinetic parameters of nortriptyline during therapeutic drug monitoring

Journal of pharmacokinetics and biopharmaceutics, 1999-02, Vol.27 (1), p.85-101

1999

Volltextzugriff (PDF)

Emergence of Resistance in Normal Human Aerobic Commensal Flora during Telithromycin and Amoxicillin-Clavulanic Acid Treatments

Antimicrobial Agents and Chemotherapy, 2003-06, Vol.47 (6), p.2030-2035

2003

Volltextzugriff (PDF)

1 – 25 von 48

Suche als RSS-Feed

Aktive Filter

ThemaMiddle Aged

ThemaMedical Sciences

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(48)
Mit Volltextzugriff
(41)

Publikationsform

Artikel
(46)
Tagungsberichte
(2)

Sprache

Englisch
(48)

Erscheinungsjahr

n.n

Thema

Biological And Medical Sciences
(48)
Life Sciences & Biomedicine
(43)
Science & Technology
(43)
Pharmacology. Drug Treatments
(39)
Pharmacology & Pharmacy
(32)
Humans
(31)
Pharmacokinetics
(17)
Models, Biological
(15)
General Pharmacology
(13)
Male
(13)
Female
(10)
Computer Simulation
(9)
Models, Statistical
(8)
Pharmacokinetics. Pharmacogenetics. Drug-Receptor Interactions
(8)
Adult
(7)
Algorithms
(7)
Animals
(7)
Computerized, Statistical Medical Data Processing And Models In Biomedicine
(7)
Bayes Theorem
(6)

14 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

The Use of Model-Based Tumor-Size Metrics to Predict Survival

Role of modelling and simulation in Phase I drug development

Development and implementation of the population Fisher information matrix for the evaluation of population pharmacokinetic designs

The ISoP Standards and Best Practices Committee

Pharmacokinetic Similarity of Biologics: Analysis Using Nonlinear Mixed-Effects Modeling

Overview of model‐building strategies in population PK/PD analyses: 2002–2004 literature survey

Hand contamination before and after different hand hygiene techniques: a randomized clinical trial

Optimal design of a population pharmacodynamic experiment for ivabradine

Pharmacokinetic and Pharmacodynamic Variability of Fluindione in Octogenarians

Comparison of lithium concentrations in red blood cells and plasma in samples collected for TDM, acute toxicity, or acute-on-chronic toxicity

Maintenance therapy with cotrimoxazole for toxoplasmic encephalitis in the era of highly active antiretroviral therapy

Population pharmacokinetic analysis and optimization of the experimental design for mizolastine solution in children

Modelling and simulation in the development and use of anti-cancer agents : An underused tool?

Modeling the Kinetics of Release of Octreotide from Long‐Acting Formulations Injected Intramuscularly in Rabbits

Fisher information matrix for non-linear mixed-effects models: evaluation and application for optimal design of enoxaparin population pharmacokinetics

Robust optimal design for the estimation of hyperparameters in population pharmacokinetics

Nonparametric analysis of the absorption profile of octreotide in rabbits from long-acting release formulation OncoLAR

Cerebral uptake of mefloquine enantiomers with and without the P‐gp inhibitor elacridar (GF1210918) in mice

Evolution of Human Immunodeficiency Virus Type 1 (HIV-1) Resistance Mutations in Nonnucleoside Reverse Transcriptase Inhibitors (NNRTIs) in HIV-1-Infected Patients Switched to Antiretroviral Therapy without NNRTIs

Absence of association between MDR1 genetic polymorphisms, indinavir pharmacokinetics and response to highly active antiretroviral therapy

Non-linear mixed effects modeling : From methodology and software development to driving implementation in drug development science

Prediction of fluindione maintenance dosage hampered by large intraindividual variability

Optimization of individual and population designs using Splus

Optimal sampling times for bayesian estimation of the pharmacokinetic parameters of nortriptyline during therapeutic drug monitoring

Emergence of Resistance in Normal Human Aerobic Commensal Flora during Telithromycin and Amoxicillin-Clavulanic Acid Treatments

Aktive Filter

Suchergebnisse filtern